{"id":"W2518726365","doi":"10.1161/jaha.116.003421","title":"Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study","year":2016,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Amgen; Daiichi-Sankyo; Regeneron Pharmaceuticals; Sanofi; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Alirocumab; Familial hypercholesterolemia; Statin; Ldl cholesterol; PCSK9; Atherosclerotic cardiovascular disease; Internal medicine; Cholesterol; LDL receptor; Total cholesterol; Lipoprotein; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001569646,0.0008694043,0.002094586,0.0002778418,0.0002850363,0.0007160191,0.0004661908,0.0007170027,0.002714157],"category_scores_gemma":[0.001250673,0.0004378786,0.001377896,0.0002972976,0.000687104,0.0006465437,0.0003854882,0.001241778,0.00045375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008235599,"about_ca_system_score_gemma":0.0009280103,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00135554,"about_ca_topic_score_gemma":0.002519162,"domain_scores_codex":[0.9994088,0.00028467,0.00004531877,0.0001095206,0.00008170638,0.00007000811],"domain_scores_gemma":[0.9990024,0.0001524277,0.0002552129,0.00007020377,0.00007001762,0.0004497253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9335629,0.009140495,0.01681406,0.0004923324,0.001514184,0.00009315741,0.000123341,0.0003770697,0.007538512,0.00008649167,0.001244531,0.0290129],"study_design_scores_gemma":[0.7570536,0.1664943,0.06943285,0.00005789934,0.001274426,0.0002938272,0.00006742677,0.001411514,0.00123799,0.0001101262,0.002509914,0.00005607977],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959339,0.002137044,0.0001664319,0.0002355655,0.00003942788,0.0003013509,0.0003950668,0.0000214507,0.0007698336],"genre_scores_gemma":[0.9947961,0.001306668,0.0005517952,0.000736095,0.0001307117,0.000406134,0.0007957483,0.00001285977,0.001263903],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002714157,"threshold_uncertainty_score":0.009079754,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01026542998422311,"score_gpt":0.2648552904499377,"score_spread":0.2545898604657146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}